Academic Journal
Q4Advanced Neurology
About Advanced Neurology
Advanced Neurology is a scholarly journal published by AccScience Publishing. SCImago 2025 lists it in Q4, with an SJR of 0.251 and H-index of 7.
Coverage: 2022-2026. Research categories: Cellular and Molecular Neuroscience (Q4); Cognitive Neuroscience (Q4); Neurology (Q4); Neuroscience (miscellaneous) (Q4).
Source-backed journal facts
Topics in published research
Alzheimer's disease research and treatments; Neuroinflammation and Neurodegeneration Mechanisms; Acute Ischemic Stroke Management; Epilepsy research and treatment; Parkinson's Disease Mechanisms and Treatments; Dementia and Cognitive Impairment Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-01. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Multi-target modulation of the neuroinflammatory network by asiatic acid in ischemic stroke: Integrated network pharmacology, molecular docking, and in vitro validation
Junjun Gong, Kok Hong Tang
2026-09-29 · DOI: 10.36922/an026310047Once‑daily antiseizure therapy: Historical development and practical optimization
Kheng-Seang Lim, Hui-Yin Yow, Si-Lei Fong
2026-09-21 · DOI: 10.36922/an026310045Integrated in silico and in vitro analysis of oxyphyllacinol in low back pain–associated neuroinflammation
Shangzhi Wu, Kok Hong Tang
2026-09-01 · DOI: 10.36922/an026200018Virtual reality interventions targeting executive functions across neurological, neurodevelopmental, neuropsychiatric, and non-clinical populations: A systematic review
Nikolaos Drakatos, Pantelis Pergantis, Andreas Petropoulos, Nikolaos Bardis et al.
2026-08-27 · DOI: 10.36922/an026290039Recent advances in neurorehabilitation
Liqun Zhang, Anthony George Rudd
2026-08-27 · DOI: 10.36922/an026310044New frontiers in Parkinson’s disease
Karim Makhoul
2026-08-21 · DOI: 10.36922/an026330052Binge eating and obesity as reward–interoception disorders: Neuroendocrine and neuromodulation perspectives
Vincenzo Maria Romeo
2026-08-18 · DOI: 10.36922/an026230025Assessment of balance function in older adults with and without subjective cognitive decline
Yuting Hu, Haixin Tang, Jie Wu, Yanan Wang et al.
2026-08-12 · DOI: 10.36922/an026280033Epilepsy advances and neuromodulation
Paul Carney
2026-08-10 · DOI: 10.36922/an026260030Spectral-conditioned hypernetworks for meta-learning neuroimaging normalization with concept-guided transparency
Hashim Ali
2026-08-04 · DOI: 10.36922/an026230024Neuroethics in pharmaceutical neuromarketing: Applications and limitations
Bhupender Nehra, Mohit Bishnoi, Manish Kumar, Navjeet Dhaka et al.
2026-07-31 · DOI: 10.36922/an026190017Neuroinflammation and neurodegeneration: Linking mechanisms, biomarkers, and therapeutic opportunity
Xinyang Zhang, Hio Lam Ho, Yuhong Fu, Zengqiang Yuan et al.
2026-07-20 · DOI: 10.36922/an026250026Neuroinflammation and neurodegeneration: Linking mechanisms, biomarkers, and therapeutic opportunity
Xinyang Zhang, Hio Lam Ho, Yuhong Fu, Zengqiang Yuan et al.
2026-07-20 · DOI: 10.36922/anFrom ventricles to lymphatics: A systems-level framework for brain fluid transport
Khaled A. Abdel-Sater
2026-07-07 · DOI: 10.36922/an026090002Safety and efficacy of indobufen versus aspirin for cerebral small vessel disease: A randomized, double-blind, double-dummy, multicenter (SEIAS) trial protocol
Ying Chen, Biying Ji, Yue Cheng, Qingxiu Zhang et al.
2026-07-07 · DOI: 10.36922/an026140005Long-term benefits of policosanol plus low dose of aspirin in the functional recovery of non-cardiogenic ischemic stroke: A randomized, placebo-controlled study
Javier Vicente Sánchez López, Julio César Fernández Travieso, Yenney Reyes Nuñez, Enmanuel Zayas Fundora et al.
2026-06-26 · DOI: 10.36922/an025410094Anoectochilus roxburghii aqueous extract improves scopolamine-induced cognitive impairment in mice: Associations with gut microbiota and fecal metabolomics
Hui Yin, Jiayi Zhang, Tao Yang, Min Feng et al.
2026-06-23 · DOI: 10.36922/an026150008Artificial intelligence in preoperative brain mapping for functional neurosurgery: A narrative review of current evidence and clinical limitations
Kimia Kazemzadeh
2026-06-12 · DOI: 10.36922/an025480120Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine
Giorgia Sciacca
2026-05-28 · DOI: 10.36922/an026210021A multidimensional review of autism spectrum disorder in Türkiye and the world
Burak Çakar, Cansu Çadırcı, Kubilay Doğan Kılıç
2026-05-28 · DOI: 10.36922/an025250073Reviews
Community Reviews
Version History
October 2, 2026 at 10:16 pm
October 2, 2026